XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS DEFICIT - USD ($)
Total
Series C, Preferred Stock
Series E, Preferred Stock
Series F, Preferred Stock
Series B, Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Mar. 31, 2019   2,305 44,000 13,441    
Balance, amount at Mar. 31, 2019 $ (56,839,098) $ 2,710,681 $ 0 $ 0 $ 44 $ 13 $ 174,804,234 $ (231,643,389)
Conversion of Series B Preferred Stock, shares   (44,000)    
Conversion of Series B Preferred Stock, amount 0 $ 0 $ 0 $ 0 $ (44) $ 0 44 0
Payment of Series B Dividend 0 $ 0 $ 0 $ 0 $ 0 $ 0 0 0
Conversion of Debenture - Abeyance, shares   25,008    
Conversion of Debenture - Abeyance, amount 0 $ 0 $ 0 $ 0 $ 0 $ 25 (25) 0
Payment for Consulting Fees, shares   600    
Payment for Consulting Fees, amount 303,340 $ 0 $ 0 $ 0 $ 0 $ 1 303,339 0
Rounding Adjustment for Split, shares   4    
Rounding Adjustment for Split, amount 0 $ 0 $ 0 $ 0 $ 0 $ 0 0 0
Series C fair value adjustment (1,637,614) (1,637,614) 0 0 0 0 1,637,614 0
Net Loss (3,451,489) $ 0 $ 0 $ 0 $ 0 $ 0 0 (3,451,489)
Balance, shares at Jun. 30, 2019   2,305 39,053    
Balance, amount at Jun. 30, 2019 (58,349,633) $ 1,073,067 $ 0 $ 0 $ 0 $ 39 176,745,206 (235,094,878)
Balance, shares at Mar. 31, 2019   2,305 44,000 13,441    
Balance, amount at Mar. 31, 2019 (56,839,098) $ 2,710,681 $ 0 $ 0 $ 44 $ 13 174,804,234 (231,643,389)
Net Loss (11,862,565)              
Balance, shares at Sep. 30, 2019   2,302 1,000,000 16,750 1,048,532    
Balance, amount at Sep. 30, 2019 (61,401,990) $ 1,156,666 $ 18,701,000 $ 1,417,000 $ 0 $ 1,049 182,102,915 (243,505,954)
Balance, shares at Mar. 31, 2019   2,305 44,000 13,441    
Balance, amount at Mar. 31, 2019 (56,839,098) $ 2,710,681 $ 0 $ 0 $ 44 $ 13 174,804,234 (231,643,389)
Net Loss 27,958,169              
Balance, shares at Mar. 31, 2020   2,819 5,000,000    
Balance, amount at Mar. 31, 2020 (79,813,325) $ 9,801,447 $ 0 $ 0 $ 0 $ 5,000 179,783,233 (259,601,558)
Balance, shares at Jun. 30, 2019   2,305 39,053    
Balance, amount at Jun. 30, 2019 (58,349,633) $ 1,073,067 $ 0 $ 0 $ 0 $ 39 176,745,206 (235,094,878)
Payment for Consulting Fees, shares   80    
Payment for Consulting Fees, amount 27,690 $ 0 $ 0 $ 0 $ 0   27,690 0
Net Loss (8,411,076)             (8,411,076)
Conversion of Series C Preferred Stock, shares   (3) 1,004,450    
Conversion of Series C Preferred Stock, amount 5,440,311 $ (682) $ 0 $ 0 $ 0 $ 1,005 5,439,306 0
Stock Compensation, shares   884    
Stock Compensation, amount 0 $ 0 $ 0 $ 0 $ 0 $ 1 (1) 0
Warrant Obeyance, shares   4,065    
Warrant Obeyance, amount 0 $ 0 $ 0 $ 0 $ 0 $ 4 (4) 0
Cash Paid for Settlement of series B Preferred Stock (25,000) $ 0 $ 0 $ 0 $ 0 $ 0 (25,000) 0
Issuance of Series E and F Preferred Stock, shares   1,000,000 16,750    
Issuance of Series E and F Preferred Stock, amount   $ 0 $ 18,701,000 $ 1,417,000 $ 0 $ 0 0 0
Series C share deemed dividends (84,282) $ 84,282 $ 0 $ 0 $ 0 $ 0 (84,282) 0
Balance, shares at Sep. 30, 2019   2,302 1,000,000 16,750 1,048,532    
Balance, amount at Sep. 30, 2019 (61,401,990) $ 1,156,666 $ 18,701,000 $ 1,417,000 $ 0 $ 1,049 182,102,915 (243,505,954)
Balance, shares at Mar. 31, 2020   2,819 5,000,000    
Balance, amount at Mar. 31, 2020 (79,813,325) $ 9,801,447 $ 0 $ 0 $ 0 $ 5,000 179,783,233 (259,601,558)
Net Loss (13,634,062) $ 0 $ 0 $ 0 $ 0 $ 0 0 (13,634,062)
Conversion of Series C Preferred Stock, shares   (498) 8,059,016    
Conversion of Series C Preferred Stock, amount 10,322,971 $ (1,213,918) $ 0 $ 0 $ 0 $ 8,059 10,314,912 0
Payment of Consulting Fees, shares   101,514    
Payment of Consulting Fees, amount 173,000 $ 0 $ 0 $ 0 $ 0 $ 102 172,898 0
Issuance of Series C Preferred Stock, shares   630    
Issuance of Series C Preferred Stock, amount (2,217,671) $ 2,217,671 $ 0 $ 0 $ 0 $ 0 (2,217,671) 0
Balance, shares at Jun. 30, 2020   2,951 13,160,530    
Balance, amount at Jun. 30, 2020 (85,169,087) $ 10,805,200 $ 0 $ 0 $ 0 $ 13,161 188,053,372 (273,235,620)
Balance, shares at Mar. 31, 2020   2,819 5,000,000    
Balance, amount at Mar. 31, 2020 (79,813,325) $ 9,801,447 $ 0 $ 0 $ 0 $ 5,000 179,783,233 (259,601,558)
Net Loss (33,620,905)              
Balance, shares at Sep. 30, 2020   2,693       25,000,000    
Balance, amount at Sep. 30, 2020 (91,871,167) $ 5,303,138       $ 25,000 201,326,296 (293,222,463)
Balance, shares at Jun. 30, 2020   2,951 13,160,530    
Balance, amount at Jun. 30, 2020 (85,169,087) $ 10,805,200 $ 0 $ 0 $ 0 $ 13,161 188,053,372 (273,235,620)
Payment for Consulting Fees, shares           75,000    
Payment for Consulting Fees, amount 36,502         $ 75 36,427 0
Series C fair value adjustment 4,981,507 $ (4,981,507)         4,981,507  
Net Loss (19,986,843)             (19,986,843)
Conversion of Series C Preferred Stock, shares   (258) 11,764,470    
Conversion of Series C Preferred Stock, amount 8,266,754 $ (520,555) $ 0 $ 0 $ 0 $ 11,764 8,254,990 0
Balance, shares at Sep. 30, 2020   2,693       25,000,000    
Balance, amount at Sep. 30, 2020 $ (91,871,167) $ 5,303,138       $ 25,000 $ 201,326,296 $ (293,222,463)